Johnson Johnson Hopes Dethrone AbbVie’s Growth Driver
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
In your 30s, reaching wealth-building milestones is crucial. Learn what to aim for to secure your financial future.
19,848 articlesTwo pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
New data highlights a tougher entry to the workforce for Gen Z graduates compared with Millennials, with a large shar...
Eastwood Homes announced it will acquire Peachtree Building Group, signaling that scale is now a mandatory criterion ...
SpaceX’s long-anticipated S-1 lays out revenue and losses, yet key subscription and launch-cost details are absent, c...
Variant has closed a $222 million fund to back early-stage startups at the intersection of AI, crypto, and autonomy. ...
SpaceX priced its IPO terms at $135 per Class A share, issuing 555.6 million shares to raise about $75 billion and va...
Morgan’s Analyst Focus List for June highlights five top passive-income dividend ideas, signaling a cautious but inco...
As AI excitement cools, investors parse the shift from trade short-term bets to a lasting investment decade. BlackRoc...
Microsoft reported a sharp jump in capital spending as it doubles down on AI infrastructure. Four-quarter CapEx now t...
Sagent has appointed Kenneth Posner as CFO to steer finance and strategy during a pivotal expansion of its Dara mortg...
DeCaro Auctions appoints Mario Vargas as CEO, signaling a bold push into private-client advisory services and cross-b...
Nscale raised billions to power Europe’s AI ambitions, but the company now confronts the need to prove it can transla...